Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
4
×
life sciences
national blog main
boston
boston blog main
clinical trials
investing
startups
boston top stories
fda
national top stories
new york blog main
san francisco blog main
achaogen
adams street partners
akouos
allosteric
antibiotics
astellas pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
beta lactamase inhibitor
beta-thalassemia
biomedical advanced research and development authority (barda)
brace pharma
california institute for biomedical research
cleva pharma
dacogen
decibel therapeutics
decitabine
dna
drug discovery
drug resistance
drugs
dupilumab
epigenetics
epizyme
What
medicines
4
×
therapeutics
4
×
developing
disease
drug
new
address
adds
affects
ago
aims
allosteric
americans
approach
approved
bacteria
based
biopharma
biotech
business
called
clinic
company
date
debuts
drugs
elusive
epigenetic
epigenetics
exited
fda
field
fighting
flagship’s
frequency
hearing
hotspot
infections
infectious
ipo
Language
unset
Current search:
medicines
×
therapeutics
×
deals
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections